Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Adc Therapeutics S.a.

Clinical trials sponsored by Adc Therapeutics S.a., explained in plain language.

ADC Therapeutics S.A. ADCT NYSE

A commercial-stage biotech company developing antibody-drug conjugates for cancer.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 2 Terminated 1

Liver-Friendly lymphoma treatment? new drug dosing study offers hope

Disease control Terminated

This study tests the safety and best dose of loncastuximab tesirine, a targeted antibody-drug conjugate, in people with relapsed or refractory diffuse large B-cell lymphoma or high-grade B-cell lymphoma who also have moderate or severe liver impairment. The goal is to find a dosi…

Phase: PHASE1 • Sponsor: ADC Therapeutics S.A. • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC